Financing, Equity Capital Markets
Praxis Precision Medicines, Inc.
03/24
|
$200.0 Million
Âé¶¹´«Ã½ served as bookrunner for Praxis Precision Medicines, Inc. on a confidentially marketed follow-on offering
Sub-Type
CMFO
Sector
Sub-Sector
Biopharma